A method for preparing PDRN from Schizochytrium
By extracting PDRN from Schizochytrium, the problem of insufficient traditional fish sperm source resources has been solved, and a low-cost, high-efficiency PDRN solution has been prepared to promote the growth of dermal papillary cells and reduce inflammation, which is suitable for cosmetics and medical fields.
Patent Information
- Application Number
- CN202310088572.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-01-17
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2043-01-17
AI Technical Summary
The traditional source of PDRN from fish progesterone is insufficient, resulting in high costs, which hinders its promotion and poses a risk of resource depletion. Therefore, it is necessary to find an alternative source that is inexpensive and readily available.
PDRN was extracted from Schizochytrium and a high-purity PDRN solution was prepared by centrifugation, lysis, precipitation, washing and ultrasonic disruption. The concentration and purity were determined using a NanoDrop micro-spectrophotometer and stored at 2-8℃.
The PDRN derived from Schizochytrium significantly promotes the growth of dermal papilla cells, has anti-inflammatory effects, and is inexpensive and readily available, making it an ideal source of PDRN suitable for products that promote hair growth and have anti-inflammatory properties.
Smart Images

Figure CN116396956B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biotechnology, and in particular relates to a method for preparing PDRN from Schizochytrium. Background Technology
[0002] Polydeoxyribonucleic acid (PDRN) is a deoxyribonucleic acid polymer with a molecular weight of 50–1500 kDa. It is primarily extracted from the sperm cells of trout or salmon and possesses various active functions, including tissue repair, anti-inflammation, and angiogenesis promotion. Currently, PDRN is widely used in various fields such as pharmaceuticals, cosmetics, and medical devices in countries like South Korea, Japan, and Europe.
[0003] Traditionally, PDRN is derived from fish testes, primarily salmon, rainbow trout, and sturgeon. While extraction from fish testes offers advantages such as ease of extraction and high purity, it also suffers from drawbacks, including insufficient availability. Firstly, salmon, rainbow trout, and sturgeon are not inexhaustible resources; overfishing can lead to depletion, and aquaculture presents technical challenges. Secondly, the growth of juvenile fish to adulthood takes time, and fish only spawn and release sperm during the breeding season, making sperm acquisition difficult. This scarcity of PDRN sources results in high costs and expensive products, hindering product promotion. Therefore, it is essential to find a high-quality yet inexpensive source of PDRN. Summary of the Invention
[0004] This invention provides a method for preparing PDRN from Schizochytrium, comprising: aspirating Schizochytrium broth into a centrifuge tube, centrifuging, discarding the supernatant, dispersing and resuspending the Schizochytrium cell clusters by high-speed turbine oscillation, adding lysis buffer, mixing, heating in a water bath at 50-80°C for complete lysis, cooling to room temperature, and obtaining the lysate. Add protein precipitation solution to the lysate, mix well until protein clumps appear, incubate on ice for at least 5 minutes, centrifuge, aspirate the supernatant, add isopropanol, mix well until flocculent DNA precipitate or white turbid precipitate appears, centrifuge, discard the supernatant, add ethanol, wash the DNA several times, centrifuge, discard the supernatant and remove the residual ethanol. The DNA precipitate was rehydrated and dissolved by adding DNA dissolving solution. The resulting DNA solution was then broken up on ice using ultrasound to obtain PDRN solution.
[0005] Furthermore, it also includes: The concentration and purity of PDRN solution were determined using a NanoDrop micro-volume spectrophotometer.
[0006] Furthermore, it also includes: The extracted PDRN solution was stored at 2-8℃.
[0007] Furthermore, it also includes: During the process of obtaining pyrolysis products by heating in a water bath, the products are thoroughly pyrolyzed by vortexing or inverting the container.
[0008] Furthermore, the volume of isopropanol added was the same as the volume of the supernatant.
[0009] Furthermore, the centrifugation rate is 4000-5000 rpm.
[0010] Furthermore, the obtained DNA solution was disrupted using an ultrasonic cell disruptor at a power of 300W, with a cooling period of 3 seconds every 2 seconds of disruption, for a total of 2 minutes.
[0011] The beneficial effects of this invention are as follows: a PDRN was extracted from *Schizochytridica*, a rapidly reproducing and low-cost plant, and it was demonstrated that it significantly promotes the growth of dermal papilla cells and inhibits inflammation within these cells, making it a highly promising hair growth promoter. Compared to PDRN derived from traditional fish semen, the PDRN extracted from *Schizochytridica* is inexpensive, readily available, and exhibits significant anti-inflammatory effects, making *Schizochytridica* an ideal source of PDRN. Attached Figure Description
[0012] To more clearly illustrate the technical solutions in the embodiments of the present invention, the accompanying drawings used in the description of the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0013] Figure 1 A graph showing the purity determination of PDRN solution provided for an embodiment of the present invention; Figure 2 A PDRN fragment size diagram provided for embodiments of the present invention; Figure 3 A diagram illustrating the effect of PDRN derived from Schizochytrium on the proliferation of DPC, provided as an embodiment of the present invention; Figure 4 A comparative diagram of the anti-inflammatory effects of PDRN derived from Schizochytrium provided in the embodiments of the present invention.
[0014] Figure 5 The effect of PDRN derived from Schizochytrium on the expression of the inflammatory factor IL-6, as provided in an embodiment of the present invention. Detailed Implementation
[0015] To enable those skilled in the art to better understand the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings.
[0016] In one embodiment of the present invention, PDRN is extracted from Schizochytrium brevicornu, as described below: 1. Extraction of PDRN from Schizochytrium (1) Take 20 ml of *Schizochytridica* spores in the logarithmic growth phase into a 50 ml centrifuge tube, centrifuge at 5000 rpm for 2 min, discarding the supernatant if necessary, or aspirate it with a pipette. Vortex at high speed to disperse and resuspend the *Schizochytridica* cell clusters. Add 20 ml of lysis buffer, vortex to mix, or repeatedly pipette with a 1 ml pipette tip to mix. The resuspension and dispersion of cells is very important for the next step of lysis, and must be fully dispersed and resuspended.
[0017] (2) Place the lysate in a 70°C water bath for 1 hour. If the yield is low, the water bath temperature and time can be increased appropriately. Vortexing can be used several times during the process to aid lysis. Allow the lysate to return to room temperature for at least 5 minutes on ice. Add 6.8 ml of protein precipitation buffer to the lysate after it has returned to room temperature, and then vortex continuously at high speed for 25 seconds. Some small protein clumps may be visible after mixing. Incubate on ice for 5 minutes. Centrifuge at at least 5000 rpm for 5 minutes. At this point, protein precipitate should be visible at the bottom of the tube, and some protein precipitate may also be seen floating on the surface of the liquid.
[0018] (3) Slowly aspirate the supernatant into a new 50ml centrifuge tube, being careful not to aspirate the precipitate. When aspirating the supernatant, be careful not to aspirate the protein precipitate at the bottom of the tube or floating on the surface of the liquid. If the protein precipitate is accidentally transferred into a new centrifuge tube, centrifuge again for 2 minutes and then collect the supernatant. Add an equal volume of room temperature isopropanol to the supernatant and mix by inverting 30 times or until flocculent DNA precipitate (or white turbid precipitate) appears. Centrifuge at at least 5000 rpm for 5 minutes. A white DNA precipitate will be visible at the bottom of the tube. Discard the supernatant.
[0019] (4) Add 20 ml of 70% ethanol, invert the tube several times to rinse the DNA precipitate, centrifuge at 5000 rpm for 2 min, discard the supernatant, invert the tube and tap it gently on absorbent paper to remove residual ethanol. You can also carefully aspirate the residual ethanol around the precipitate and on the tube wall with a pipette tip, and air dry the precipitate for a few minutes. Be careful not to over-dry it, otherwise the DNA will be extremely difficult to dissolve; also, do not leave too much ethanol, otherwise the ethanol may inhibit downstream reactions such as enzyme digestion.
[0020] (5) Add 1-3 ml of DNA dissolving buffer to rehydrate and dissolve the DNA precipitate, obtaining a DNA solution. Dissolve the obtained DNA solution using an ultrasonic cell disruptor at 300 W on ice, cooling for 3 seconds every 2 seconds of disruption, for a total of 2 minutes, to obtain a PDRN solution. Determine the concentration and purity of the PDRN solution using a NanoDrop micro-spectrophotometer. Perform 1% agarose gel electrophoresis on the PDRN solution to identify fragment sizes. The extracted PDRN solution can be stored at 2-8°C; for long-term storage, it can be placed at -20°C.
[0021] 2. Result Testing like Figure 1 As shown, 260nm is the absorption wavelength of the highest absorption peak for nucleic acids, 280nm is the absorption wavelength of the highest absorption peak for proteins and phenols, and 230nm is the absorption wavelength of the highest absorption peak for carbohydrates. The A260 / A280 and A260 / A230 ratios are generally used to test the purity of DNA and RNA. The A260 / A280 ratio for pure DNA is approximately 1.8, and the A260 / A280 ratio for pure RNA is approximately 2.0. An A260 / A280 ratio < 1.8 indicates protein or phenol contamination, while an A260 / A230 ratio < 2.0 indicates carbohydrate (sugar), salt ion, or organic solvent contamination. The purity of PDRN is shown in the figure. Figure 1 As shown, A260 / A280=1.80 and A260 / A230=2.07, indicating that the PDRN purity is very good and there is no contamination from proteins or organic solvents.
[0022] PDRN fragment size as Figure 2 As shown, lane 1 is DNAmarker2000, lane 2 is unbroken genomic DNA, and lane 3 is PDRN after sonication for 2 minutes. The electrophoresis diagram shows that the complete genomic DNA fragments are very large, while the PDRN fragments are between 100-2000 bp in size.
[0023] 3. Effects of PDRN derived from Schizochytrium on the proliferation of dermal papillary cells Dermal papilla cells (DPCs) are the tissue center for the cyclical renewal of hair follicles. On one hand, they secrete a large number of cytokines through paracrine mechanisms, stimulating the differentiation, proliferation, and migration of epithelial stem cells and melanocyte stem cells in the hair follicle protuberance area, thus initiating hair generation. On the other hand, DPCs coordinate the regulation of the hair growth cycle by modulating the stem cell microenvironment, such as the size of the dermal papilla, the distance between the dermal papilla and the hair follicle protuberance area, and the lymphatic drainage and nerve innervation around the hair follicle protuberance area. Therefore, exploring effective chemical substances or natural extracts that can repair and stimulate DPC growth is of great significance for the treatment of hair loss.
[0024] Experimental Procedure: Dermal papillary cells (DPCs) were purchased from Meisen CTCC (Zhejiang, China). DPCs were cultured in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37°C and 5% CO2 humidified air. The effect of PDRN on DPC cell viability was detected using the CCK-8 assay (HY-K0301, MCE, China). In short, DPCs (3 × 10⁻⁶ cells / year) were viable at 37°C and 5% CO2 humidified air. 3 DPCs (cells / well) were seeded in 96-well plates and cultured for 24 h. The old culture medium was discarded, and each well was washed twice with 100 μl D-PBS. DPCs were then treated with 10–320 μg / ml PDRN for 24 h. After 24 h of culture, the culture medium was discarded, and each well was washed twice with 100 μl D-PBS. 100 μl DMEM and 10 μl CCK-8 were added to each well, and the plates were incubated at 37°C with 5% CO2 for 1 h. Finally, absorbance was measured at 450 nm. Each treatment was performed in triplicate. Cell proliferation was calculated by comparing absorbance values.
[0025] The results are as follows Figure 3 As shown, PDRN derived from *Schizochytridica* exhibited a concentration-dependent growth-promoting effect on DPC within the concentration range of 10-320 μg / ml. Compared with the control group, PDRN increased the proliferation rate of DPC by 14.54%-49.61%, with the best performance observed at 320 μg / ml PDRN, which increased the proliferation rate by 49.61% compared to the control group. These results indicate that PDRN derived from *Schizochytridica* has no toxic effect on DPC and can significantly promote DPC proliferation, thus having a positive effect on hair growth.
[0026] 4. Anti-inflammatory effects of PDRN derived from Schizochytrium Follicular inflammation is a major cause of hair loss. To investigate the anti-inflammatory effect of PDRN derived from Schizochytrium, the CCK-8 assay was used to determine the effect of PDRN on DPC activity after inflammation induction. The study showed that the mechanism of action of PDRN from traditional sources is to specifically stimulate A2A adenosine receptors on the cell surface, thereby promoting the release of cytokines, producing an anti-inflammatory effect, and repairing damaged cells.
[0027] Experimental Procedure: DPCs (3 × 10³ cells / well) were seeded in 96-well plates and cultured for 24 h. Then, *E. coli* lipopolysaccharide (LPS) (20 μg / ml) was added for 2 h to induce DPC inflammation. Next, DPCs were treated with 100 μg / ml PDRN and 10 μM A2A adenosine receptor antagonist ZM241385 for 24 h, respectively. After 24 h of culture, the culture medium was discarded, and each well was washed twice with 100 μl D-PBS. 100 μl DMEM and 10 μl CCK-8 were added to each well, and the wells were incubated at 37°C in a humidified incubator with 5% CO2 for 1 h. Finally, absorbance was measured at 450 nm. Each treatment was performed in triplicate. Cell viability was compared by comparing absorbance values.
[0028] The results are as follows Figure 4 As shown, compared with the control group, LPS reduced DPC activity by 25.61%, indicating successful induction of DPC inflammation. This inflammation then inhibited DPC activity. However, the addition of PDRN derived from *Schizochytrium* reversed this trend, with DPC activity decreasing by only 17.68%, a 7.93% increase compared to the LPS group, indicating that PDRN has anti-inflammatory effects. ZM241385 is an A2A adenosine receptor antagonist. The addition of ZM241385 inhibited the promoting effect of PDRN, indicating that PDRN mainly exerts its effects by activating A2A adenosine receptors, exhibiting similar efficacy to PDRN from traditional sources.
[0029] 5. Effect of PDRN derived from Schizochytrium on the expression of the inflammatory cytokine IL-6 Interleukin-6 (IL-6) is an important pro-inflammatory cytokine released during infection or tissue damage. This study used *E. coli* lipopolysaccharide (LPS) to induce inflammation, and then used qPCR to detect the effect of PDRN derived from *Schizochytrium* on IL-6 expression.
[0030] Experimental steps: DPC (3×10) 3DPCs were seeded in 96-well plates (10 cells / well) and incubated at 37°C with 5% CO2 for 24 h. Then, *E. coli* lipopolysaccharide (LPS) (20 μg / ml) was added for 2 h to induce DPC inflammation. DPCs were then treated with 100 μg / ml PDRN, the A2A adenosine receptor agonist CGS21680 (10 μM), and the A2A adenosine receptor antagonist ZM241385 (10 μM), respectively, for 24 h. After 24 h of treatment, DPCs were collected, and total RNA was extracted using TRIzol reagent (Solarbio, Cat #R1100). cDNA was synthesized using the PrimeScript™ RT kit and gDNA Eraser (Takara, Cat #RR047A). Quantitative RT-qPCR was performed using TB Green® Premix Ex TaqII (Takara, Cat #RR820A) and ABI QuantStudio 6 Flex (ABI, USA). The cycling protocol was as follows: one cycle at 95℃ for 30 s, followed by 40 cycles of 95℃ for 5 s, 60℃ for 30 s, and finally 95℃ for 15 s, 60℃ for 1 min, and 95℃ for 15 s. IL-6 primer sequences: F: 5'-TGGGGCTGCTCCTGGTGTTG-3'; R: 5'-GAGGTGAGTGGCTGTCTGTG-3'; GADPH primer sequences: F: 5'-GACAGTCAGCCGCATCTTCT-3'; R: 5'-GCGCCCAATACGACCAAATC-3'. Relative gene expression levels were calculated as 2^-ΔΔCt, with GADPH normalized as a housekeeping gene.
[0031] The results are as follows Figure 5 As shown, after LPS (20 μg / ml) treatment, the expression level of IL-6 in DPC was 109.63 times that of the control group, indicating that LPS successfully induced inflammation. Compared with the LPS group, the expression level of IL-6 decreased by 21.08% after adding PDRN derived from Schizochytrium, indicating that PDRN has excellent anti-inflammatory effects. In addition, the addition of the A2A adenosine receptor agonist CGS21680 also reduced the expression level of IL-6, while the addition of the A2A adenosine receptor antagonist ZM241385 inhibited the anti-inflammatory effect of PDRN, further demonstrating that the anti-inflammatory mechanism of PDRN derived from Schizochytrium is the same as that of PDRN derived from traditional fish sperm, which works by activating the A2A adenosine receptor.
[0032] This invention uses *Schizochytridica* as raw material. High-purity, uncontaminated genomic DNA is extracted and then disrupted on ice using an ultrasonic cell disruptor at 300W for 2 seconds, followed by a 3-second cooling period. The resulting fragments are 100-2000 bp in size, yielding a PDRN solution. PDRN from *Schizochytridica* can promote hair growth by stimulating dermal papilla cell proliferation, with an effective concentration range of 10-500 μg / ml. PDRN from *Schizochytridica* can also inhibit dermal papilla cell inflammation, reduce hair follicle inflammation, and prevent hair loss, with an effective concentration range of 10-500 μg / ml.
[0033] PDRN was extracted from *Schizochytridica*, a rapidly reproducing and low-cost plant, and demonstrated to significantly promote dermal papillary cell growth and inhibit inflammation within these cells, making it a highly promising hair growth promoter. Compared to PDRN derived from traditional fish semen, PDRN extracted from *Schizochytridica* is inexpensive, readily available, and exhibits significant anti-inflammatory effects, making it an ideal source of PDRN.
[0034] Obviously, the above embodiments are merely illustrative examples for clear explanation and are not intended to limit the implementation. Those skilled in the art will recognize that other variations or modifications can be made based on the above description. It is neither necessary nor possible to exhaustively list all possible implementations here. However, obvious variations or modifications derived therefrom are still within the scope of protection of this invention.
[0035] The above description is only a partial embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A method for preparing PDRN from Schizochytrium, characterized in that, include: The logarithmic growth phase of the Schizochytrium broth was aspirated into a centrifuge tube, centrifuged, and the supernatant was discarded. The Schizochytrium cell clusters were then dispersed and resuspended by high-speed turbine oscillation. The lysis buffer was added, mixed well, and heated in a water bath at 50-80℃ for complete lysis. The mixture was then cooled to room temperature to obtain the lysate. Add protein precipitation solution to the lysate, mix well until protein clumps appear, incubate on ice for at least 5 minutes, centrifuge, aspirate the supernatant, add isopropanol, mix well until flocculent DNA precipitate or white turbid precipitate appears, centrifuge, discard the supernatant, add ethanol, wash the DNA several times, centrifuge, discard the supernatant and remove the residual ethanol. The DNA precipitate was rehydrated and dissolved by adding DNA dissolving solution. The resulting DNA solution was then broken up on ice using ultrasound to obtain PDRN solution. The centrifugation rate is 4000-5000 rpm; The obtained DNA solution was disrupted using an ultrasonic cell disruptor at a power of 300W, with a cooling period of 3 seconds every 2 seconds of disruption, for a total of 2 minutes.
2. The method according to claim 1, characterized in that, Also includes: The concentration and purity of PDRN solution were determined using a NanoDrop micro-volume spectrophotometer.
3. The method according to claim 1, characterized in that, Also includes: The extracted PDRN solution was stored at 2-8℃.
4. The method according to claim 1, characterized in that, Also includes: During the process of obtaining pyrolysis products by heating in a water bath, the products are thoroughly pyrolyzed by vortexing or inverting the container.
5. The method according to claim 1, characterized in that, The volume of isopropanol added is the same as the volume of the supernatant.
Citation Information
Patent Citations
Method for isolating polydeoxyribonucleotides from semen of fish, polydeoxyribonucleotides obtained by same and use of same
CN107287186A
Application of schizochytrium limacinum grease extract in promotion of hair growth or prevention and treatment of alopecia
CN115054618A
